Stay up to date with the latest breaking news, analysis and commentary on Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Sun Pharmaceutical Industries has launched Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI).
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India.
NIIT shares locked in 20% upper circuit after Ramesh Damani acquires stake in co
26 Aug 2024, 10:41AMNIIT shares locked in 20% upper circuit after Ramesh Damani acquires stake in co
26-08-2024 10:41:44Indian stock markets open higher on the first day of the week.
26-08-2024 09:33:24Sun Pharma introduces a novel treatment, STARIZO
23-08-2024 15:40:06Budget 2024 Analysis
